Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults
- PMID: 22628157
- PMCID: PMC3418456
- DOI: 10.1002/ajmg.b.32071
Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults
Abstract
The neuropathogenesis of HIV-associated neurocognitive disorders (HAND) is unclear. Candidate gene studies have implicated genetic susceptibility loci within immune-related genes; however, these have not been reliably validated. Here, we employed genome-wide association (GWA) methods to discover novel genetic susceptibility loci associated with HAND, and validate susceptibility loci implicated in prior candidate gene studies. Data from 1,287 participants enrolled in the Multicenter AIDS Cohort Study between 1985 and 2010 were used. Genotyping was conducted with Illumina 1M, 1MDuo, or 550K platform. Linear mixed models determined subject-specific slopes for change over time in processing speed and executive functioning, considering all visits including baseline and the most recent study visit. Covariates modeled as fixed effects included: time since the first visit, depression severity, nadir CD4+ T-cell count, hepatitis C co-infection, substance use, and antiretroviral medication regimen. Prevalence of HIV-associated dementia (HAD) and neurocognitive impairment (NCI) was also examined as neurocognitive phenotypes in a case-control analysis. No genetic susceptibility loci were associated with decline in processing speed or executive functioning among almost 2.5 million single nucleotide polymorphisms (SNPs) directly genotyped or imputed. No association between the SNPs and HAD or NCI were found. Previously reported associations between specific genetic susceptibility loci, HIV-associated NCI, and HAD were not validated. In this first GWAS of HAND, no novel or previously identified genetic susceptibility loci were associated with any of the phenotypes examined. Due to the relatively small sample size, future collaborative efforts that incorporate this dataset may still yield important findings.
Copyright © 2012 Wiley Periodicals, Inc.
Figures


References
-
- AAN. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(6):778–85. - PubMed
-
- Achim CL, Wiley CA. Inflammation in AIDS and the role of the macrophage in brain pathology. Curr Opin Neurol. 1996;9(3):221–5. - PubMed
-
- Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27(1):86–92. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 MH100929/MH/NIMH NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- U01 MH083500/MH/NIMH NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- AI28697/AI/NIAID NIH HHS/United States
- P30 NS062691/NS/NINDS NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- P30 AI028697/AI/NIAID NIH HHS/United States
- U01 MH083545/MH/NIMH NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01MH083500/MH/NIMH NIH HHS/United States
- R03 DA026099/DA/NIDA NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- P30NS062691/NS/NINDS NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- R01 NS080655/NS/NINDS NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials